FDC declines after Q4 PAT slips 16% to Rs 47 cr

Read more about FDC declines after Q4 PAT slips 16% to Rs 47 cr on Business Standard. FDC fell 4.41% to Rs 332 after the company's consolidated net profit skid 16.3% to Rs 46.76 crore on 6% decline in net sales to Rs 313.40 crore in Q4 March 2021 over Q4 March 2020.

Related Keywords

,Capital Market ,Pharmaceuticals Nec ,Pharmaceutical Research ,Nutraceuticals ,Biotechnology ,Sangean Rs 332 Portable Audio Device ,Dc ,Biotechnology Products ,மூலதனம் சந்தை ,மருந்துகள் கழுத்து ,டச் ,